Change of lung function in severe eosinophilic asthma undergoing treatment with anti-interleukin-5 monoclonal antibody
L. Antonicelli (Ancona, Italy), A. Gobbi (Milan, Italy), M. Bilò (Ancona, Italy), M. Garritani (Ancona, Italy), M. Brianzoni (Ancona, Italy), R. Dellacà (Milano, Italy)
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Disease area: Airway diseases
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: